TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vistin Pharma ASA
Closing information (x1000 NOK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
287,675
|
275,812
|
253,159 |
| Financial expenses |
9,466
|
7,322
|
183,893 |
| Earnings before taxes |
-6,008
|
31,995
|
-124,271 |
| Total assets |
407,214
|
333,146
|
321,915 |
| Current assets |
159,182
|
137,831
|
141,526 |
| Current liabilities |
117,795
|
41,035
|
32,204 |
| Equity capital |
273,263
|
275,768
|
272,405 |
| - share capital |
44,345
|
44,345
|
44,345 |
| Employees (average) |
0
|
0 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
67.1%
|
82.8%
|
84.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-2.1%
|
11.6%
|
-49.1% |
| Return on assets (ROA) |
0.8%
|
11.8%
|
18.5% |
| Current ratio |
135.1%
|
335.9%
|
439.5% |
| Return on equity (ROE) |
-2.2%
|
11.6%
|
-45.6% |
| Change turnover |
11,863
|
22,653
|
25,030 |
| Change turnover % |
4%
|
9%
|
11% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.